About Us

The COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. The key partners are the International Agency for Research on Cancer (IARC), The International Cancer Screening Network (ICSN), the Canadian Partnership Against Cancer (CPAC) and Cancer Council NSW, Sydney Australia (which is the coordinating centre for the CCGMC). We have established key links to groups from WHO and the National Cancer Institute USA’s CISNET program who have related work programs.

Our aim is to help to configure modelling platforms and teams that can provide more informed advice to our governments, in both high income countries and in in low- and middle-income countries as they rise to this overwhelming health systems challenge. Our focus on the longer-term, as well as the shorter-term, recognises that recovery strategies will be required as countries move beyond the acute phase of the crisis.

We are connecting teams who are already working on the infectious disease dynamics in various countries, with a collaborative effort to establish global platforms for cancer control. We are utilising the best available cancer registry and Globocan data, synthesising this information with emergent evidence on treatment uptake and evidence on the effectiveness of new therapies for cancer patients impacted by COVID-19.

We have now received over 270 registrations through the online EOI, with representation across 38 countries, covering a wide range of specialities and with interest across the three different components of work – impact on cancer treatment, screening and cancer prevention (as described in the Concept Note).

The Steering Committee members are:

  • Prof Karen Canfell (Coordinating Centre, Cancer Council NSW, COVID and Cancer Taskforce Member, co-Chair across the three CCGMC Working Groups)
  • Dr Freddie Bray (IARC representative, COVID and Cancer Taskforce Member, co-Chair Working Group 1 – Treatment)
  • Dr Rami Rahal (CPAC representative)
  • A/Prof Iris Lansdorp-Vogelaar (ICSN representative, co-Chair Working Group 2 – Screening)
  • Dr Isabelle Soerjomataram (co-Chair Working Group 3 – Prevention)
  • Dr Ophira Ginsburg (co-Chair Working Group 3 – Prevention)

The Working Group Structure across these three components of work are illustrated below. 

Graphic titled 'Proposed working group structure'.  Three working groups are featured for each of Cancer Treatment, Screening and Prevention.

Terms of Reference for the CCGMC and Disclosures

The Terms of Reference for the Consortium have now been confirmed.

The CCGMC requires all Consortium members declare any circumstances that may create potential conflict of interest in the area(s) they will be involved. Please complete and sign the Disclosure of Interest form and return to the Secretariat at covidandcancer@nswcc.org.au for review. All members must complete this form before participation in any CCGMC working group activities. Please note, only one form is required, regardless of the number of working groups you are involved in.

Our affiliates

The CCGMC acknowledges contributors at an institutional and collaborative group level, and those supporting the purpose and the work of the Consortium. Please refer to the Terms of Reference for a detailed outline of the partnership criteria and expectations. If you are interested in becoming a partner organisation of the CCGMC, please send an email to cancerandcovid@nswcc.org.au outlining your request for consideration by the Taskforce.

The CCGMC acknowledges the contributions of our Affiliates: